Almac uses HP Software to bring drugs to market faster
Almac Group, a global pharmaceutical services provider based in Ireland, has used HP software to reduce the time required to put new drugs through clinical trials.
Almac Group, a global pharmaceutical services provider based in Ireland, has used HP software to reduce the time required to put new drugs through clinical trials.
Every drug under development must be scrutinised in a clinical trial, which requires customised software applications that go through a complex compliance and validation process before the trial can proceed. By using HP Quality Center software to automate the testing process for these applications, Almac has reduced the validation time by months, which means that drugs for cancer and other illnesses can get to patients faster.
"By using HP technology we help speed the move from innovation to clinical practice, resulting in significant market advantage and enhanced competitiveness for our customers across the world," said Sir Allen McClay, chairman of Almac Group.
Almac has achieved full pharmaceutical validation for HP Quality Center software, enabling it to automate its approach to software validation and testing.
Martin Murphy, HP's managing director for Northern Ireland, added: "HP is helping Almac shorten the validation aspects of its software development while at the same time ensuring that it can meet manufacturing best practices globally."
Almac Group
info@almacgroup.com
